New Generation Vaccines

Klappentext

Reports on recent developments in the understanding of immunity at the molecular and cellular levels that is applicable to the search for novel immunological adjuvants and the formulation of new-generation vaccines for experimental and clinical use. The adjuvants are necessary for the effectiveness

Inhalt

Dendritic Cells; J.M. Austyn. The Multiple Accessory Cell Concept; M. Van Rooijen. Sythetic Peptides and the Role of T-Helper Cell Determinants; M.J. Francis. Carriers for Peptides; M.J. Francis. Co-Entrapment of T-Cell and B-Cell Peptides in Liposomes Overcomes Genetic Restriction in Mice and Induces Immunological Memory; G. Gregoriadis, et al. Preparation and Characterization of Stable Liposomal Hepatitis B Vaccine; D. Diminsky, et al. Initiation of Immune Response with ISCOM; B. Morein, et al. Nanoparticles as Potent Aduvants for Vaccines; J. Kreuter. Optimization of Carriers and Adjuvants; A. Snidjders, et al. Immunotargeting as an Adjuvant Independent Subunit Vaccine Design Option; D.L. Skea, B.H. Barber. BCG Vaccine; M.J. Groves, et al. Significance of Virulence Factors and ImmunoEvasion for the Design of Gene-Deleted Herpesvirus Marker Vaccines; S. Kit. Eradication of Sylvatic Rabies Using a Live Recombinant Vaccinia-vRabies Vaccine; M.P. Kieny, et al. 7 additional articles. Index.